<table> 					 					     <tr> 						   <td> 						    <img src="https://www.microbiozindia.com/uploaded_files/magazine_images/ZEISS-ZEN-Core-Software-Suite-Offers-New-Analysis-and-Connectivity-Modules37_54.png"> 						   </td> 						   <td> 						   <h3>ZEISS ZEN Core Software Suite Offers New Analysis and Connectivity Modules</h3> 						   <p>ZEISS ZEN core is a powerful software suite for microscopy imaging, automated analyses, and multi-modal workflows in connected materials laboratory environments. With the new release, materials researchers are now even more efficient. </p>						   </td> 						  </tr>  						 					     <tr> 						   <td> 						    <img src="https://www.microbiozindia.com/uploaded_files/magazine_images/Waters-Addresses-Increasing-Demands-for-Higher-Performing-Materials-with-New-TA-Innovations-at-Pittcon46_35.png"> 						   </td> 						   <td> 						   <h3>Waters Addresses Increasing Demands for Higher Performing Materials with New TA Innovations at Pittcon</h3> 						   <p>Waters Corporation has announced the availability of a range of new TA Instruments™ innovations headlined by the Discovery™ </p>						   </td> 						  </tr>  						 					     <tr> 						   <td> 						    <img src="https://www.microbiozindia.com/uploaded_files/magazine_images/Renishaw-Technology-Used-to-Identify-Microplastics-in-the-Environment50_07.png"> 						   </td> 						   <td> 						   <h3>Renishaw Technology Used to Identify Microplastics in the Environment</h3> 						   <p>Could rubber and plastic from tyres, washing into rivers and streams, be contributing to pollution in waste water? A group of scientists from Denmark are using a system from Renishaw to find out. </p>						   </td> 						  </tr>  						 					     <tr> 						   <td> 						    <img src="https://www.microbiozindia.com/uploaded_files/magazine_images/Biogen-investors-worst-fears-have-come-true-with-the-failure-of-its-phase-three-Alzheimers52_38.png"> 						   </td> 						   <td> 						   <h3>Biogen investors worst fears have come true with the failure of its phase three Alzheimers</h3> 						   <p>Biogen investors&rsquo; worst fears have come true with the failure of its phase 3 Alzheimer&rsquo;s prospect, and now, it may be &ldquo;buy or be bought&rdquo; time for the Big Biotech.</p>						   </td> 						  </tr>  						 					  </table>